Isabelle Paty

722 total citations
16 papers, 485 citations indexed

About

Isabelle Paty is a scholar working on Cognitive Neuroscience, Experimental and Cognitive Psychology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Isabelle Paty has authored 16 papers receiving a total of 485 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cognitive Neuroscience, 6 papers in Experimental and Cognitive Psychology and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Isabelle Paty's work include Sleep and related disorders (6 papers), Sleep and Wakefulness Research (3 papers) and Forensic Toxicology and Drug Analysis (3 papers). Isabelle Paty is often cited by papers focused on Sleep and related disorders (6 papers), Sleep and Wakefulness Research (3 papers) and Forensic Toxicology and Drug Analysis (3 papers). Isabelle Paty collaborates with scholars based in Netherlands, United Kingdom and France. Isabelle Paty's co-authors include Alain Patat, Mona Darwish, Ian Hindmarch, Wim J. Riedel, Annemiek Vermeeren, Martin P.J. van Boxtel, Philippe Danjou, Edmund R. Volkerts, Joris C. Verster and Dieuwke S. Veldhuijzen and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, SLEEP and Journal of Thrombosis and Haemostasis.

In The Last Decade

Isabelle Paty

15 papers receiving 462 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Isabelle Paty Netherlands	9	207	178	102	75	70	16	485
Haiqing Lin China	10	113 0.5×	60 0.3×	123 1.2×	29 0.4×	61 0.9×	25	373
Dyan Sellayah United Kingdom	11	104 0.5×	163 0.9×	222 2.2×	79 1.1×	215 3.1×	19	756
Rey-Yue Yuan Taiwan	13	27 0.1×	74 0.4×	181 1.8×	13 0.2×	14 0.2×	17	502
Susanne Bokmand Denmark	9	96 0.5×	67 0.4×	38 0.4×	79 1.1×	120 1.7×	11	478
Slava Berger United States	13	37 0.2×	135 0.8×	50 0.5×	23 0.3×	262 3.7×	18	505
Renjun Lv China	9	40 0.2×	52 0.3×	110 1.1×	36 0.5×	116 1.7×	23	424
J. Antosiewicz Poland	8	71 0.3×	64 0.4×	31 0.3×	20 0.3×	189 2.7×	17	411
Yulu Gu China	14	26 0.1×	119 0.7×	206 2.0×	84 1.1×	13 0.2×	38	621
Alice Riva Italy	10	111 0.5×	44 0.2×	86 0.8×	65 0.9×	4 0.1×	21	494

Countries citing papers authored by Isabelle Paty

Since Specialization

Citations

This map shows the geographic impact of Isabelle Paty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabelle Paty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabelle Paty more than expected).

Fields of papers citing papers by Isabelle Paty

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabelle Paty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabelle Paty. The network helps show where Isabelle Paty may publish in the future.

Co-authorship network of co-authors of Isabelle Paty

This figure shows the co-authorship network connecting the top 25 collaborators of Isabelle Paty. A scholar is included among the top collaborators of Isabelle Paty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabelle Paty. Isabelle Paty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

1.

Abplanalp, Wesley, Ariane Fischer, David John, et al.. (2020). Efficiency and Target Derepression of Anti-miR-92a: Results of a First in Human Study. Nucleic Acid Therapeutics. 30(6). 335–345. 112 indexed citations

2.

Esdonk, Michiel J. van, Frederik E. Stuurman, Nienke R. Biermasz, et al.. (2018). A Novel Somatostatin-Dopamine Chimera (BIM23B065) Reduced GH Secretion in a First-in-Human Clinical Trial. The Journal of Clinical Endocrinology & Metabolism. 104(3). 883–891. 13 indexed citations

3.

Cortez, Pierre, et al.. (2012). Bioequipotency of idraparinux and idrabiotaparinux after once weekly dosing in healthy volunteers and patients treated for acute deep vein thrombosis. British Journal of Clinical Pharmacology. 75(5). 1255–1264. 4 indexed citations

4.

Paty, Isabelle, et al.. (2010). Reversibility of the anti‐FXa activity of idrabiotaparinux (biotinylated idraparinux) by intravenous avidin infusion. Journal of Thrombosis and Haemostasis. 8(4). 722–729. 44 indexed citations

5.

Stone, Barbara M., Claire Turner, Isabelle Paty, et al.. (2002). Noise‐induced sleep maintenance insomnia: hypnotic and residual effects of zaleplon. British Journal of Clinical Pharmacology. 53(2). 196–202. 17 indexed citations

6.

Vermeeren, Annemiek, Wim J. Riedel, Martin P.J. van Boxtel, et al.. (2002). Differential Residual Effects of Zaleplon and Zopiclone on Actual Driving: a Comparison with a Low Dose of Alcohol. SLEEP. 25(2). 224–31. 90 indexed citations

7.

Verster, Joris C., Edmund R. Volkerts, A.H.C.M.L. Schreuder, et al.. (2002). Residual Effects of Middle-of-the-Night Administration of Zaleplon and Zolpidem on Driving Ability, Memory Functions, and Psychomotor Performance. Journal of Clinical Psychopharmacology. 22(6). 576–583. 108 indexed citations

8.

Hindmarch, Ian, Alain Patat, Neil Stanley, Isabelle Paty, & Una Rigney. (2001). Residual effects of zaleplon and zolpidem following middle of the night administration five hours to one hour before awakening. Human Psychopharmacology Clinical and Experimental. 16(2). 159–167. 39 indexed citations

9.

Patat, Alain, Isabelle Paty, & Ian Hindmarch. (2001). Pharmacodynamic profile of Zaleplon, a new non‐benzodiazepine hypnotic agent. Human Psychopharmacology Clinical and Experimental. 16(5). 369–392. 28 indexed citations

10.

Hindmarch, Ian, Alain Patat, Neil Stanley, Isabelle Paty, & Una Rigney. (2001). Residual effects of zaleplon and zolpidem following middle of the night administration five hours to one hour before awakening. Human Psychopharmacology Clinical and Experimental. 16(2). 159–167.

11.

Vermeeren, Annemiek, N. D. Muntjewerff, Wim J. Riedel, et al.. (2000). Residual effects of zaleplon and zopiclone versus the effects of alcohol on actual car driving performance. European Neuropsychopharmacology. 10. 394–394. 4 indexed citations

12.

Darwish, Mona, Isabelle Paty, Alain Patat, & Steven Troy. (2000). Comparison of psychomotor and memory impairment with zaleplon versus other hypnotics: an integrated analysis. European Neuropsychopharmacology. 10. 394–395. 2 indexed citations

13.

Volkerts, Edmund R., Joris C. Verster, Dieuwke S. Veldhuijzen, et al.. (2000). The impact on car-driving performance of zaleplon or zolpidem administration during the night. European Neuropsychopharmacology. 10. 395–395. 7 indexed citations

14.

Carcas, Antonio J., et al.. (2000). Absence of an interaction between ibuprofen and zaleplon. American Journal of Health-System Pharmacy. 57(12). 1137–1141. 9 indexed citations

15.

Hindmarch, I., Neil Stanley, Isabelle Paty, & Alain Patat. (2000). Comparison of the residual effects of zaleplon and zolpidem after administration during the night. European Neuropsychopharmacology. 10. 394–394. 2 indexed citations

16.

Paty, Isabelle, et al.. (2000). Effect of zaleplon on digoxin pharmacokinetics and pharmacodynamics. American Journal of Health-System Pharmacy. 57(24). 2267–2270. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact